Skip to main content
. 2022 Feb 22;12(3):327. doi: 10.3390/life12030327
5-FU Fluorouracil
AE Adverse events
ALT Alanine aminotransferase
AST Aspartate aminotransferase
CNTs concentrative nucleoside transporters
CTCAE Common Terminology Criteria for Adverse Events
CR Complete response
ENTs Equilibrative nucleoside transporters
FOLFIRINOX Chemotherapy regimen containing fluorouracil, folinic acid, irinotecan, and oxaliplatin
MMRI Molecular magnetic resonance imaging
NP/G Nab-paclitaxel plus gemcitabine
ORR Objective response rate
OS Overall survival
PDAC Pancreatic ductal adenocarcinoma
PFS Progression-free survival
PR Partial response
PRISMA Preferred Reporting Items for Systematic Reviews
TNBC Triple-negative breast cancer
TNM Tumor/Node/Metastasis staging system from the American Joint Committee on Cancer
UTI Urinary tract infection